Selective A1-adenosine receptor antagonists identified using yeast Saccharomyces cerevisiae functional assays

被引:29
作者
Campbell, RM [1 ]
Cartwright, C [1 ]
Chen, W [1 ]
Chen, Y [1 ]
Duzic, E [1 ]
Fu, JM [1 ]
Loveland, M [1 ]
Manning, R [1 ]
McKibben, B [1 ]
Pleiman, CM [1 ]
Silverman, L [1 ]
Trueheart, J [1 ]
Webb, DR [1 ]
Wilkinson, V [1 ]
Witter, DJ [1 ]
Xie, XB [1 ]
Castelhano, AL [1 ]
机构
[1] Cadus Pharmaceut Corp, Tarrytown, NY 10591 USA
关键词
D O I
10.1016/S0960-894X(99)00398-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Evaluation of a biased "library" of pyrrolo[2,3-d]pyrimidines using yeast-based functional assays expressing human A(1)- and A(2a)-adenosine receptors, led to the A(1) selective antagonist 4b. A direct correlation between yeast functional activity and binding data was established. Practical compounds with polar residues at C-4 of the pyrrolopyrimidine system required H-bond donor functionality for high potency. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2413 / 2418
页数:6
相关论文
共 17 条
[1]   Canine mast cell adenosine receptors: Cloning and expression of the A(3) receptor and evidence that degranulation is mediated by the A(2B) receptor [J].
Auchampach, JA ;
Jin, XW ;
Wan, TC ;
Caughey, GH ;
Linden, J .
MOLECULAR PHARMACOLOGY, 1997, 52 (05) :846-860
[2]  
Broach JR, 1996, NATURE, V384, P14
[3]  
BRUNS RF, 1986, MOL PHARMACOL, V29, P331
[4]  
DeNinno M.P., 1998, ANNU REP MED CHEM, V33, P111
[5]   Adenosine A2B receptors:: a novel therapeutic target in asthma? [J].
Feoktistov, I ;
Polosa, R ;
Holgate, ST ;
Biaggioni, I .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (04) :148-153
[6]   Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors [J].
Gray, NS ;
Wodicka, L ;
Thunnissen, AMWH ;
Norman, TC ;
Kwon, SJ ;
Espinoza, FH ;
Morgan, DO ;
Barnes, G ;
LeClerc, S ;
Meijer, L ;
Kim, SH ;
Lockhart, DJ ;
Schultz, PG .
SCIENCE, 1998, 281 (5376) :533-538
[7]   Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes [J].
Kim, YC ;
de Zwart, M ;
Chang, L ;
Moro, S ;
Kunzel, JKVD ;
Melman, N ;
IJzerman, AP ;
Jacobson, KA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (15) :2835-2845
[8]  
KONTEATIS ZD, 1994, J IMMUNOL, V153, P4200
[9]   A(1)-adenosine receptor antagonists [J].
Muller, CE .
EXPERT OPINION ON THERAPEUTIC PATENTS, 1997, 7 (05) :419-440
[10]  
Muller CE, 1996, CURR PHARM DESIGN, V2, P501